BIOGEN INC. is 4.3x more valuable than Arcellx, Inc. by market capitalization ($28.73 B vs $6.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACLX | BIIB |
|---|---|---|
| Market cap | $6.73 B | $28.73 B |
| US-listed rank | #1180 | #480 |
| Revenue (latest FY) | $22.29M | $9.89B |
| Net income (latest FY) | -$228.93M | $1.29B |
| Net margin | -1027.3% | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 448 | 2,690 |
BIOGEN INC. is 4.3x more valuable than Arcellx, Inc. by market capitalization ($28.73 B vs $6.73 B).
In their latest fiscal years, Arcellx, Inc. reported $22.29M in revenue while BIOGEN INC. reported $9.89B.
Full pages: Arcellx, Inc. and BIOGEN INC., or browse the full rankings.